Healios K.K. (OTCMKTS:HLOSF – Get Free Report) saw a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 663,299 shares, a growth of 347.0% from the January 15th total of 148,399 shares. Based on an average trading volume of 140 shares, the days-to-cover ratio is currently 4,737.9 days. Based on an average trading volume of 140 shares, the days-to-cover ratio is currently 4,737.9 days.
Healios K.K. Stock Performance
Shares of OTCMKTS:HLOSF remained flat at $2.10 during trading on Wednesday. Healios K.K. has a 52 week low of $1.90 and a 52 week high of $4.45. The company has a 50-day simple moving average of $2.15 and a 200-day simple moving average of $3.22.
Healios K.K. Company Profile
Healios K.K. is a Tokyo–based biotechnology company focused on the development and commercialization of regenerative medicine products and services. The company’s core expertise lies in induced pluripotent stem cell (iPSC)–derived therapies, with a pipeline that includes retinal pigment epithelium (RPE) cells for age‐related macular degeneration and neural cell products targeting neurological disorders. Healios operates a specialized cell processing center in Chuo‐ku, Tokyo, adhering to stringent quality standards for clinical‐grade cell manufacturing.
Beyond its proprietary programs, Healios provides contract development and manufacturing services (CDMO) to pharmaceutical and research institutions.
Featured Stories
- Five stocks we like better than Healios K.K.
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
